Medication info
Megateldepine Tablet 40/5 mg

Megateldepine Tablet 40/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
It is a white and light gray, double convex oval tablet.
Packaging
30 tablets/box [30 tablets (10 tablets/PTP X 3)]
Approval status
Active

MFDS item code 202000047 · Approved 2020.01.03 · Insurance code 060500210

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section “3. Patients Requiring Caution”). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for essential hypertension where blood pressure is not adequately controlled by monotherapy with telmisartan or amlodipine.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section “3. Patients Requiring Caution”). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication may cause serious harm to the fetus if used during pregnancy, especially in the second and third trimesters, and should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with specific conditions. For example, patients allergic to this medication or similar ingredients, pregnant or breastfeeding women, patients with obstructive biliary disease, severe liver impairment, serious heart problems, hypotensive patients, unstable heart failure after acute myocardial infarction, and diabetic patients with specific kidney diseases should not take this medication. Caution is advised when using this medication in certain patient populations, such as those with primary aldosteronism, patients with aortic or mitral stenosis, patients with liver diseases, gastrointestinal disease patients, renal artery hypertension patients, patients undergoing dialysis, elderly patients, and those using other medications affecting the renin-angiotensin-aldosterone system. Common side effects like dizziness or edema may occur while using this medication, and in rare cases, fainting or serious allergic reactions can occur. Additionally, a decrease in blood pressure, gastrointestinal disturbances, liver function abnormalities, skin rashes, myalgia, and renal function impairment have been reported, thus, if any abnormal symptoms occur, immediate consultation with a healthcare professional is required. The use of this medication during pregnancy may have serious effects on the fetus; therefore, if planning to become pregnant or upon confirmation of pregnancy, immediate discontinuation and switching to a safer treatment option is recommended. It is also advisable for breastfeeding women not to take this medication. As this medication lowers blood pressure, patients at risk for hypotension should check their fluid or salt status before taking it, and appropriate measures should be taken immediately if hypotension symptoms appear. Due to the risk of hyperkalemia, blood potassium levels should be monitored regularly, and caution is advised when taking potassium supplements or potassium-containing medications. Patients with impaired renal function may experience changes in kidney function while using this medication; therefore, frequent blood tests to monitor kidney function are recommended. For patients with heart disease, the risk of angina or myocardial infarction may increase after taking this medication; thus, attention to changes in symptoms is necessary. This medication may cause drowsiness or dizziness; therefore, caution is advised when driving or operating hazardous machinery. There may be interactions with other medications when taken together, so it is essential to inform your healthcare professional of any other medications you are taking, especially when combined with specific heart medications, diuretics, lithium, warfarin, grapefruit juice, etc. In case of overdose, symptoms like hypotension, cardiac arrhythmias, dizziness, and acute renal failure may occur; therefore, immediate medical attention is required.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 102 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • altered taste
  • tremor
  • extrapyramidal disorder
  • hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • tendon pain
  • renal impairment
  • acute renal failure
  • urination disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it should be stored at room temperature between 1°C and 30°C, in conditions that are not too hot or too cold, for optimal effectiveness.

Appearance and packaging

Appearance

It is a white and light gray, double convex oval tablet.

Package unit

30 tablets/box [30 tablets (10 tablets/PTP X 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.